Multicenter phase II study evaluating docetaxel, CDDP [cisplatin], and cetuximab as induction regimen prior to surgery in chemo-naive patients with NSCLC [non-small cell lung cancer] stage IB, II and IIIA.

Trial Profile

Multicenter phase II study evaluating docetaxel, CDDP [cisplatin], and cetuximab as induction regimen prior to surgery in chemo-naive patients with NSCLC [non-small cell lung cancer] stage IB, II and IIIA.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs Cetuximab (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 10 Mar 2011 Planned end date changed from 1 Dec 2009 to 1 Jun 2011 as reported by ClinicalTrials.gov.
    • 26 Aug 2010 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top